Sort
53,477 grants matching “addiction”
The National Drug Abuse Clinical Trials Network: New England Consortium Node
$771,914Gail D'onofrio · Yale University · UG1 · FY2022 · DA
Respect, Trust, and Patient Outcomes in Sickle Cell Disease
$771,750Mary Catherine Beach · Johns Hopkins University · R01 · FY2013 · HL
Multi-modal profiling of spatially resolved cell types mediating opioid withdrawal
$771,668Xiaoke Chen · Stanford University · R01 · FY2025 · DA
Small Regulatory RNAs
$771,612Gisela Storz · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2010 · HD
The Genetic Basis of Opioid Dependence Vulnerablility in a Rodent Model
$771,565Peter W Kalivas · Medical University Of South Carolina · U01 · FY2019 · DA
Clinical Trials Network: The Texas Node
$771,469Madhukar H Trivedi · Ut Southwestern Medical Center · UG1 · FY2017 · DA
RURAL EXPANSION OF MEDICATION TREATMENT FOR OPIOID USE DISORDER (CTN-0102). AUGUST 1, 2024 TO MARCH 31, 2026. N01DA-22-2253. TASK ORDER NO. 75N95024F00008 (TO24).
$771,451Jennifer McCormack · The Emmes Company, Llc · N01 · FY2024 · DA
Advancing the science on recovery community centers to support persons treated with medications for opioid use disorder
$771,374John F Kelly · Massachusetts General Hospital · R24 · FY2022 · DA
Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in Cancer
$771,175Alex Toker · Beth Israel Deaconess Medical Center · R35 · FY2020 · CA
Study in Outpatient Medicine using Nudges to improve Sleep: The SOMNUS Trial
$771,112Jason N Doctor · University Of Southern California · R01 · FY2023 · HL
Neurobehavioral Determinants of Health Risk Behaviors: From Adolescence to Young Adulthood
$770,967Jungmeen Kim · Virginia Polytechnic Inst And St Univ · R01 · FY2021 · DA
The circadian rhythm as a lentiviral vector restriction factor
$770,756Tal Kafri · Univ Of North Carolina Chapel Hill · R01 · FY2020 · HL
OUTREACH: Opioid Use TReatment via telehEAlth in CHCs
$770,751Steffani R Bailey · Oregon Health & Science University · R01 · FY2025 · DA
Synthetic Psychoactive "Bath Salt" Effects on Brain Activity and Behavior
$770,638Stephen John Kohut · Mclean Hospital · R01 · FY2022 · DA
Project 4: Using a prospective cohort survey to test population-level predictions generated by Projects 1-3
$770,621Joanna E Cohen · Virginia Commonwealth University · U54 · FY2021 · DA
Oncogenic mechanisms and molecular targets in myeloma
$770,465Louis Staudt · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
RNA interference-based screens for molecular targets in cancer
$770,465Louis Staudt · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Police Pathways to Addiction Treatment, Health, and Safety: The Police PATHS Study
$770,461Brandon Del Pozo · Rhode Island Hospital · R01 · FY2025 · DA
Clinical Trials Network: The Texas Node
$770,396Madhukar H Trivedi · Ut Southwestern Medical Center · U10 · FY2012 · DA
Entry and Engagement in Methadone Maintenance Treatment
$770,386Robert P Schwartz · Friends Research Institute, Inc. · R01 · FY2006 · DA
Environmental Tobacco Smoke Reduction in Preteens
$770,230Melbourne F Hovell · San Diego State University · R01 · FY2006 · HL
Preventing School Exclusion and Opioid Misuse: Effectiveness of the Inclusive Skill-building Learning Approach (ISLA)
$770,082Rhonda Nese · University Of Oregon · R01 · FY2023 · DA
Clinical Trials Network: Southwest Node
$770,000Michael Parks Bogenschutz · University Of New Mexico · U10 · FY2010 · DA
Center to Improve System Performance of Substance Use Disorder Treatment
$769,819Constance M Horgan · Brandeis University · P30 · FY2015 · DA
Implementation to motivate physician response to opioid dependence in HIVsetting
$769,749Peter D. Friedmann · Baystate Medical Center, Inc. · R01 · FY2018 · DA